Cynthia E Hawkins Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

5/2017

Spatial heterogeneity in medulloblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cynthia E Hawkins Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 07/2005
13	Medulloblastoma 01/2021 - 07/2005
6	Brain Neoplasms (Brain Tumor) 01/2019 - 12/2009
5	Glioma (Gliomas) 01/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
3	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 02/2009
3	Ependymoma 01/2016 - 07/2010
2	Turcot syndrome 01/2021 - 01/2016
2	Diffuse Intrinsic Pontine Glioma 01/2018 - 01/2016
2	Primitive Neuroectodermal Tumors (PNET) 08/2014 - 12/2009
2	Epilepsy (Aura) 03/2012 - 07/2008
1	Microsatellite Instability 01/2021
1	Carcinogenesis 12/2020
1	Circulating Neoplastic Cells 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2017
1	Neuroblastoma 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Splenomegaly 11/2013
1	Hemorrhage 11/2013
1	Thrombosis (Thrombus) 11/2013
1	Chromothripsis 08/2012
1	Cap Myopathy 04/2010
1	Muscle Hypotonia (Hypotonia) 01/2008
1	Brain Diseases (Brain Disorder) 01/2008
1	Stroke (Strokes) 01/2008
1	Coma (Comas) 01/2008
1	Muscular Diseases (Myopathy) 01/2008
1	Cognitive Dysfunction 01/2008
1	Cardiomyopathies (Cardiomyopathy) 01/2008
1	Seizures (Absence Seizure) 01/2008
1	Brain Contusion 09/2007
1	Anemia 09/2007
1	Muscle Weakness 08/2006

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2005
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 02/2009
3	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2011
3	Formaldehyde (Formol)FDA Link 01/2016 - 04/2011
2	Immune Checkpoint InhibitorsIBA 12/2020 - 01/2016
2	dipinacoline glutamateIBA 01/2018 - 01/2016
2	Genetic Markers (Genetic Marker)IBA 05/2017 - 06/2015
2	ParaffinIBA 01/2016 - 03/2014
1	acetyl- glycyl- valyl- allo- isoleucyl- seryl- glutaminyl- isoleucyl- arginyl- prolyl- cysteinamideIBA 01/2021
1	PeptidomimeticsIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	Exonucleases (3' 5' Exonuclease)IBA 12/2020
1	CateninsIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Interleukin-13IBA 01/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2016
1	2- O- (6- O- glycero- manno- heptopyranosyl- glucopyranosyl)glucopyranoseIBA 01/2016
1	Histones (Histone)IBA 01/2016
1	LithiumIBA 12/2014
1	Radiation-Sensitizing AgentsIBA 12/2014
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2014
1	von Willebrand FactorIBA 11/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2013
1	Platelet Factor 4IBA 11/2013
1	P-SelectinIBA 11/2013
1	Actins (F Actin)IBA 04/2010
1	FilaminsIBA 07/2008
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2008
1	Oxygen (Dioxygen)IBA 09/2007
1	DystrophinIBA 08/2006

Therapy/Procedure

17	Therapeutics 01/2021 - 11/2005
3	Drug Therapy (Chemotherapy) 10/2016 - 08/2012
2	Immunotherapy 01/2021 - 12/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2018
1	Image-Guided Radiotherapy 01/2016
1	Cytoreduction Surgical Procedures 01/2016
1	Radiotherapy 01/2016
1	Chemoradiotherapy 01/2016
1	Craniospinal Irradiation 01/2016
1	Lasers (Laser) 11/2013
1	Re-Irradiation 08/2012
1	Hemodilution 09/2007